sur Cantourage Group SE (isin : DE000A3DSV01)
Cantourage Responds to Proposed Cannabis Law Changes with Strategic Moves
On October 8, 2025, following a resolution by the German government proposing significant changes to medical cannabis regulations, Cantourage Group SE announced strategies to address potential impacts. The draft bill mandates in-person consultations for prescriptions, which may temporarily lower the demand for cannabis flowers. Many patients currently rely on telemedicine services for their needs.
Philip Schetter, CEO of Cantourage, criticizes the proposed changes, suggesting they would complicate access to medical cannabis and risk industry growth in Germany. In response, Cantourage continues international expansion in markets like Poland and the UK, enhancing its resilience against domestic regulatory changes.
The company's ongoing product diversification in Germany aims to maintain patient supply amidst evolving regulations, affirming Cantourage's commitment to adaptive solutions for future challenges.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Cantourage Group SE